Impact of lymph node metastases in esophageal carcinoma patients is independent of patient age

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 3, 2011, Pages 599-603

  Sehitogullari, Abidin ^a   Cikman, Oztekin ^a   Sayir, Fuat ^a   Cobanoglu, Ufuk ^a   Demir, Cengiz ^a   Demir, Halit ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Age groups; Esophageal cancer; Lymph node metastasis; Survey

Indexed keywords

EID: 79958827871     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Axon PR, Simo R, Temple RH, et al (2000). Carcinoma of the hypopharinx and cervical esophagus in young adults. Ann Otol Rhinol Laryngol, 109, 590-3.
2. Boyle MJ, Franceschi D, Livingstone AS (1999). Transhiatal versus transthoracic esophagectomy: complication and survival rates. Am Surg, 65, 1137-41.
3. Cariati A, Casano A, Campagna A, et al (2002). Prognostic factors influencing morbidity and mortality in esophageal carcinoma. Rev Hosp Clin Fac Med Sao Paulo, 57, 201-4.
4. Casas F, Ferrer F, Farrus B, et al (1997). Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer, 80, 1366-72.
5. Cheng KK (1994). The etiology of esophageal cancer in Chinese. Semin Oncol, 21, 411-5.
6. Chu KM, Law SY, Fok M, et al (1997). A prospective randomized comparison of transhiatal and transthoracic resection for lower third esophageal carcinoma. Am J Surg, 174, 320-4.
7. Clark GW, Peters JH, Ireland AP, et al (1994). Nodal metastasis and sites of recurrence after enblock esophagectomy for adenocarcinoma. Ann Thorac Surg, 58, 646-53.
8. Daly JM, FryWA, Little AG, et al (2000). Esophageal cancer: results of an American college of surgeons patient care evaluation study. J Am Coll Surg, 190, 562-72.
9. Demir H, Akkus ZA, Cebi A, et al (2010). Catalase, carbonic anhydrase and other biochemical parameters in esophageal cancers in Turkey. Asian Pac J Cancer Prev, 11, 1029-32.
10. Devesa SS, Blot WJ, Fraumeni JF (1998). Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer, 83, 2049-53.
11. Ellis FH Jr (1999). Standard resection for cancer of the esophagus and cardia. Surg Oncol Clin N Am, 8, 279-94.
12. EloubeidiMA, Desmond R, ArguedasMR, et al (2002). Prognostic factors for the survival of patients with esophageal carcinoma in the U.S. The importance of tumor length and lymph node status. Cancer, 95, 1434-43.
13. Fisher S, Brady L. Esophagus. In: Perez CA, Brady LJ (eds) (1998). Principles and Practice of Radiation Oncology, 3rd edn. Philadelphia, PA: lippincott-raven, 1241-56.
14. Holmes RS, Vaughan TL (2007). Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol, 17, 2-9.
15. Holscher AH, Bollschweiler E, Schneider PM, et al (1995). Prognosis of early esophageal cancer: comparison between adeno- and squamous cell carcinoma. Cancer, 76, 178-86.
16. Hussey DH, Barakley T, Bloedorn F (1980). Carcinoma of the esophagus. in: Fletcher G H (ed.). Textbook of Radiotherapy, 3rd edn. Philadelphia, PA: Lea & Febiger, 688.
17. Imai T, Sannohe Y, Okano H (1978). Oat cell carcinoma (apudoma) of the esophagus: a case report. Cancer, 41, 358-64.
18. Koshy M, Esiashvilli N, Landry JC, et al (2004). Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist, 9, 137-46.
19. Lagergren J (2005). Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut, 54, 1-5.
20. Law SY, Fok M, Cheng SW (1992). A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia. Surg Gynecol Obstet, 175, 107-12.
21. Levine MS (1997). Esophageal cancer: radiologic diagnosis. Radiol Clin North Am, 35, 265-79.
22. Levine MS, Halvorsen RA (2000). Carcinoma of the esophagus. in: Gore RM, Levine MS (eds). Textbook of Gastrointestinal Radiology. Philadelphia, PA: WB Saunders, 403-33.
23. Lightdale CJ (2000). Positron emission tomography: another useful test for staging esophageal cancer. J Clin Oncol, 18, 3199-201.
24. Mariette C, Finzi L, Piessen G, et al (2005). Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg, 29, 39-45.
25. Pearson JG (1977). The present status and future potential of radiotherapy in the management of esophageal cancer. Cancer, 39, 882-90.
26. Portale G, Peters JH, Hsieh CC, et al (2004). Esophageal adenocarcinoma in patients _50 years old: delayed diagnosis and advanced disease at presentation. Am Surg, 70, 954-8.
27. Rice TW, Adelstein DJ (1997). Precise clinical staging allows treatment modification of patients with esophageal carcinoma. Oncology, 11, 58-62.
28. Rindani R, Martin CJ, Cox MR (1999). Transhiatal versus ivor- lewis oesophagectomy: is there a difference? Aust N Z J Surg, 69, 187-94.
29. Schrump D, Altorki N, Forastiere A (2001). Cancer of the esophagus. in: De Vita VT Jr, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology, 6th edn. Philadelphia, PA: Lippincott-Williams & Wilkins, 1319-42.
30. Siewert JR, Stein HJ, Feith M, et al (2001). Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the western world. Ann Surg, 234, 360-7.
31. Tachibana M, Dhar DK, Kinugasa S, et al (2002). Esophageal cancer patients surviving 6 years after esophagectomy. Langenbecks Arch Surg, 387, 77-83.
32. Tilanus HW (1995). Changing patterns in the treatment of carcinoma of the esophagus. Scand J Gastroenterol Suppl, 212, 38-42.
33. Visbal AL, Allen MS, Miller DL, et al (2001). Ivor lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg, 71, 1803-8.
34. Watson A (1994). Operable esophageal cancer: current results from the west. Word J Surg, 18, 361-6.
35. Wong RK, Malthaner RA, Zuraw L, et al (2003). Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys, 55, 930-42.